INS and cancer: T2D, often combined with obesity, induces hormonal changes by increasing insulin resistance, inflammation with increased Interleukin 6, and increased reactive oxygen species, all of which can lead to hyperinsulinemia and insulin-stimulated mitosis by directly affecting cancer cell proliferation [54].